TAE Life Sciences raises $40m for neutron beam cancer treatment

March 13, 2018 By Fink Densford Leave a Comment

TAE Life Sciences said yesterday it raised $40 million in venture capital to support the development of its neutron beam technology designed as a potential treatment for head and neck, glioblastoma multiforme and other cancers.

The newly launched Foothill Ranch, Calif.-based company, which operates as a subsidiary of fusion energy company TAE Technologies, is developing neutron beam technology intended for Boron Neutron Capture Therapy.

As part of the company’s launch, it announced that it is partnering with Chinese BNCT company Neuboron Medtech, and that its first neutron beam system will be delivered to Neuboron for its first medical use.

“I am pleased to be publicly launching TAE Life Sciences, and for the opportunity to provide solutions for aggressive and late-stage cancer with promising new applications of accelerator-based neutron beam technology. BNCT has been investigated as a promising area of treatment for some time, but challenged by the limited radiation options for convenient clinical practice. Now, TAE Life Sciences stands ready to offer a compelling and compassionate application of medical science innovation, increasing accessibility to treatment options for a challenging disease, and improving outcomes for patients around the world,” TAE Life Sciences CEO Bruce Bauer said in a press release.

BNCT is designed to treat multi-centric, sometimes inoperable tumors diffusely embedded in normal tissue intended to provide minimal harm to healthy cells. TAE Life Science’s proprietary BNCT platform includes a tunable neutron beam and compact form factor, the company said.

Funding in the round was led by Artis Ventures, and TAE Life Sciences said it plans to work with clinical research partners to investigate the use of accelerator-based BNCT to hasten development of its proprietary beam systems as it pursues regulatory clearance.

“TAE Life Sciences has a differentiated platform in the world of nuclear medicine and oncology, and is backed by strong, early results. Their seasoned team has already shown they can execute in a short period of time while continuing to garner interest from across the globe. As early lead investors, we look forward to helping TAE Life Sciences in a similar capacity as our work with Stemcentrx. Both companies have striking similarities in their potential to reshape the future of oncology,” Artis Ventures co-founder and prez Stuart Peterson said in a prepared statement.

From the Hospital Bed to the Finish Line

Heidi Dohse was diagnosed with a rare arrhythmia in 1982 and has been 100% pacemaker dependent for over 30 years. With the help of wearable devices, she has been able to pursue her dream to become a competitive cyclist.

You can hear her story and more when you register for DeviceTalks Boston, October 8-10.

REGISTER NOW

Use code FINISHLINE to save an additional 10%.

What is a lithium thionyl chloride battery and how does it work?
Sol Jacobs, VP and GM, Tadiran Batteries What is a lithium thionyl chloride battery? Under the broad category of primary lithium battery types, numerous types of primary (non-rechargeable) lithium battery chemistries are commercially-available that differ in their performance characteristics. The critical considerations are voltage, discharge current, service life and temperature range. LiCFX (poly carbon monofluoride) and LiMN02 […]
Integrated Computer Solutions launches Boston UX firm
Integrated Computer Solutions recently launched Boston UX, a user experience design consultancy that specializes in developing intuitive interface design for smart devices like medical devices, industrial controls and IoT and consumer devices. Boston UX was created as a result of ICS seeing an increasing demand for UX design services over the last three years. The […]
The 20 largest medical device companies in the world
The medical device industry saw even more consolidation over the past year, as evidenced by Medical Design & Outsourcing‘s newest Big 100 list. It used to be that a company had to have at least $100 million in annual revenue to make it on the list. This time around, No. 100 on the list is […]
Saranas demonstrates Early Bird in first endovascular cases
Saranas said today that the first clinical cases using its Early Bird endovascular bleed monitoring system were performed at Atlantic Health System’s Morristown Medical Center in Morristown, N.J. The Early Bird device includes a vascular access sheath with embedded sensors that are designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, […]
MedAutonomic implants device to treat metabolic syndrome
MedAutonomic said today it has successfully implanted a brain neuromodulation device, the Phoenix, into the stomach wall of a human through an innovative digestive endoscopic procedure. Powered without a battery, the Phoenix sends signals to the limbic system to reset an imbalance in the autonomic nervous system to treat metabolic syndrome and functional diseases such […]
Meditech Spine wins FDA nod for spinal implant system
Meditech Spine said today it has received FDA 510(k) clearance to market the CURE Opel-C Plate spinal implant system, an add-on technology to its already cleared CURE anterior cervical plate (ACP) system and Talos-C hydroxyapatite (HA) interbody systems. With this approval, Meditech will now offer two additional CURE ACP plating options with its Talos […]
Zavation, PanMed join forces in spinal device market
Spinal hardware and biologics company Zavation Medical Products (Jackson, Miss.) said today that it has partnered with the management team of Pan Medical U.S. Corp. to buy that company. PanMed (Tampa, Fla.) designs, develops and manufactures highly complex medical products including balloons, catheters, needles, and instrument kits used in minimally invasive procedures, primarily in kyphoplasty […]
Freudenberg Medical touts catheter handle platform and steerable introducers
Freudenberg Medical is touting its new catheter handle platform and its steerable introducer products. The Composer XL Deflectable Catheter Handle Platform gives users a commercialization-ready interface that is designed to give integrated control, according to the company. It is sized for large bore structural heart and endovascular devices like transcatheter tricuspid and mitral valve delivery […]
Livongo touts first connected BP monitor
Consumer digital health company Livongo Health today announced the first cellular-enabled blood pressure monitoring system in the U.S. Cellular connectivity allows for easy checking and reporting from home, eliminating the so-called “white coat” syndrome that leads to unnecessary prescriptions for high blood pressure, the company said in a prepared statement. Nearly 65% of people already […]
BMF Material Technology to use Onshape software for high-precision manufacturing
BMF Material Technology, a provider of micro/nano-scale 3D printing and precision manufacturing, has picked up Onshape’s 3D cloud CAD platform, the companies said today. Officials at BMF (Shenzhen City, China) think Cambridge, Mass.–based Onshape‘s real-time data management platform will enable them to speed up collaboration and communication with customers, helping them optimize their CAD models. Micro/nano-scale […]
Medtronic joins initiative to bring more women into the board room
Medtronic (NYSE:MDT) said today that it joined the Catalyst CEO Champions For Change initiative, pledging to add more women to its executive team and board of directors. The medtech titan teamed up with global nonprofit Catalyst and promised that it would “strengthen the pipeline of women” within the organization using annual reviews and data tracking. Get […]